LOS ANGELES, March 24, 2025 (GLOBE NEWSWIRE) — As the face of artificial intelligence keeps changing, CrushOn.AI has outshined once again with its NSFW Character AI Girlfriend Chat facility. With its best-in-class technology, simplicity, and complete focus on privacy, CrushOn.AI is now one of the best AI chat websites to
Peru becomes the 25th international location to embrace eXp Realty’s fast-growing global network eXp Realty Launches in Peru, Creating Unmatched Opportunities for Agents to Build Their Future Peru becomes the 25th international location to embrace eXp Realty’s fast-growing global network BELLINGHAM, Wash., March 21, 2025 (GLOBE NEWSWIRE) — eXp Realty®,
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize
The agreement gives Angelini Pharma an option to exclusive licensing rights to develop and commercialize CV-011, a clinical Phase 1 investigational novel compound with broad potential to treat brain health diseases Cureverse receives undisclosed upfront payments and is eligible for future milestone-dependent payments and royalties, while retaining rights to commercialize
Collaboration to include the clinical development, regulatory filing, and commercialization in Japan of 177Lu-PSMA-I&T and 64Cu-PSMA-I&T Builds on long-standing relationship between the two companies In Japan around 90,000 new cases of prostate cancer are diagnosed each year PARIS, Oct. 01, 2024 (GLOBE NEWSWIRE) — Curium, a world leader in nuclear
